13D/13G Filings - Nantahala Capital Management, LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, ...13, 14, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
4:32 pm
Purchase
2024-12-31 13G Anebulo Pharmaceuticals, Inc.
ANEB
Nantahala Capital Management, LLC 3,547,398
8.630%
3,547,398increase
(New Position)
Filing
History
2025-02-14
4:32 pm
Purchase
2024-12-31 13G Apyx Medical Corporation
APYX
Nantahala Capital Management, LLC 3,493,235
9.990%
3,493,235increase
(New Position)
Filing
History
2025-02-14
4:32 pm
Sale
2024-12-31 13G BlackSky Technology Inc.
BKSY
Nantahala Capital Management, LLC 1,377,060
4.470%
-1,072,940decrease
(-43.79%)
Filing
History
2025-02-14
4:32 pm
Sale
2024-12-31 13G Cellectar Biosciences, Inc.
CLRB
Nantahala Capital Management, LLC 2,507,125
5.730%
-1,170,614decrease
(-31.83%)
Filing
History
2025-02-14
4:32 pm
Sale
2024-12-31 13G CONNS INC
CONNQ
Nantahala Capital Management, LLC 1,389,773
5.580%
-874,805decrease
(-38.63%)
Filing
History
2025-02-14
4:32 pm
Purchase
2024-12-31 13G DarioHealth Corp.
DRIO
Nantahala Capital Management, LLC 3,512,946
9.990%
458,014increase
(+14.99%)
Filing
History
2025-02-14
4:32 pm
Sale
2024-12-31 13G Establishment Labs Holdings Inc.
ESTA
Nantahala Capital Management, LLC 1,682,688
6.100%
-676,453decrease
(-28.67%)
Filing
History
2025-02-14
4:32 pm
Purchase
2024-12-31 13G Eventbrite, Inc.
EB
Nantahala Capital Management, LLC 5,930,947
7.300%
5,930,947increase
(New Position)
Filing
History
2025-02-03
4:47 pm
Purchase
2025-02-03 13D Evoke Pharma, Inc.
EVOK
Nantahala Capital Management, LLC 254,639
15.990%
7increase
(+0.00%)
Filing
History
2024-12-20
4:32 pm
Purchase
2024-12-19 13G Unicycive Therapeutics, Inc.
UNCY
Nantahala Capital Management, LLC 10,879,142
9.990%
719,793increase
(+7.09%)
Filing
History
2024-11-14
4:53 pm
Purchase
2024-09-30 13G Abeona Therapeutics Inc.
ABEO
Nantahala Capital Management, LLC 4,426,382
9.990%
1,926,601increase
(+77.07%)
Filing
History
2024-11-14
4:53 pm
Purchase
2024-09-30 13G CONNS INC
CONNQ
Nantahala Capital Management, LLC 2,264,578
9.100%
2,264,578increase
(New Position)
Filing
History
2024-11-14
4:53 pm
Purchase
2024-09-30 13G DarioHealth Corp.
DRIO
Nantahala Capital Management, LLC 3,054,932
9.990%
293,792increase
(+10.64%)
Filing
History
2024-11-14
4:53 pm
Sale
2024-09-30 13G DHI Group, Inc.
DHX
Nantahala Capital Management, LLC 2,376,606
4.910%
-263,081decrease
(-9.97%)
Filing
History
2024-11-14
4:53 pm
Purchase
2024-09-30 13G Elutia Inc.
ELUT
Nantahala Capital Management, LLC 2,983,568
9.990%
1,070,792increase
(+55.98%)
Filing
History
2024-11-14
4:53 pm
Sale
2024-09-30 13G enVVeno Medical Corporation
NVNO
Nantahala Capital Management, LLC 1,285,857
7.056%
-113,731decrease
(-8.13%)
Filing
History
2024-11-14
4:53 pm
Sale
2024-09-30 13G Establishment Labs Holdings Inc.
ESTA
Nantahala Capital Management, LLC 2,359,141
8.543%
-111,013decrease
(-4.49%)
Filing
History
2024-11-14
4:53 pm
Sale
2024-09-30 13G Evolus, Inc.
EOLS
Nantahala Capital Management, LLC 2,824,849
4.477%
-86,000decrease
(-2.95%)
Filing
History
2024-11-14
4:53 pm
Purchase
2024-09-30 13G Fulcrum Therapeutics, Inc.
FULC
Nantahala Capital Management, LLC 4,777,912
7.657%
4,777,912increase
(New Position)
Filing
History
2024-11-14
4:53 pm
Purchase
2024-09-30 13G Aprea Therapeutics, Inc.
APRE
Nantahala Capital Management, LLC 411,520
7.300%
411,520increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3, ...13, 14, Next